- Report
- October 2024
- 120 Pages
United States
From €5421EUR$5,950USD£4,568GBP
- Report
- January 2025
- 126 Pages
Europe
From €2732EUR$2,999USD£2,302GBP
- Report
- July 2024
- 124 Pages
North America
From €2732EUR$2,999USD£2,302GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3525EUR$3,869USD£2,970GBP
- Report
- January 2025
- 93 Pages
Europe
From €3143EUR$3,450USD£2,649GBP
- Report
- January 2025
- 88 Pages
North America
From €3143EUR$3,450USD£2,649GBP
- Report
- January 2025
- 73 Pages
Africa, Middle East
From €3143EUR$3,450USD£2,649GBP
- Report
- December 2024
- 88 Pages
Asia Pacific
From €3143EUR$3,450USD£2,649GBP
- Report
- September 2024
- 94 Pages
North America
From €3143EUR$3,450USD£2,649GBP
- Report
- September 2024
- 94 Pages
Europe
From €3143EUR$3,450USD£2,649GBP
- Report
- September 2024
- 90 Pages
Asia Pacific
From €3143EUR$3,450USD£2,649GBP
- Report
- July 2024
- 109 Pages
North America
From €3143EUR$3,450USD£2,649GBP
- Report
- July 2024
- 109 Pages
Middle East, Africa
From €3143EUR$3,450USD£2,649GBP
- Report
- July 2024
- 113 Pages
Europe
From €3143EUR$3,450USD£2,649GBP
- Report
- July 2024
- 113 Pages
Asia Pacific
From €3143EUR$3,450USD£2,649GBP
- Report
- May 2025
- 85 Pages
United States
From €3189EUR$3,500USD£2,687GBP
- Report
- April 2025
- 82 Pages
United States
From €3189EUR$3,500USD£2,687GBP
- Report
- June 2025
United States
From €1909EUR$2,095USD£1,608GBP
€3635EUR$3,990USD£3,063GBP
- Report
- June 2025
Middle East
From €1909EUR$2,095USD£1,608GBP
€3635EUR$3,990USD£3,063GBP
- Report
- June 2025
Asia Pacific
From €1909EUR$2,095USD£1,608GBP
€3635EUR$3,990USD£3,063GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more